Cowen Prime Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-300
Closed -$25K 222
2018
Q1
$25K Sell
300
-28,160
-99% -$2.22M 0.01% 159
2017
Q4
$2.05M Sell
28,460
-20,070
-41% -$1.38M 1% 30
2017
Q3
$3.09M Sell
48,530
-4,400
-8% -$276K 1.47% 24
2017
Q2
$3.3M Buy
52,930
+35
+0.1% +$2.07K 1.52% 20
2017
Q1
$2.82M Buy
52,895
+11,295
+27% +$610K 1.45% 20
2016
Q4
$2.23M Buy
41,600
+700
+2% +$35.6K 1.2% 25
2016
Q3
$2.13M Buy
40,900
+1,800
+5% +$91.1K 0.97% 29
2016
Q2
$1.86M Buy
+39,100
New +$1.85M 0.9% 29
2015
Q2
Sell
-500
Closed -$23K 307
2015
Q1
$23K Hold
500
0.01% 219
2014
Q4
$22K Buy
+500
New +$20.3K 0.01% 231
2013
Q3
Sell
-375
Closed -$12K 298
2013
Q2
$12K Buy
+375
New +$12.1K 0.01% 227

Other funds holding ZTS

Cowen Prime Advisors's ZTS Position: Q2 2018 in Review

Cowen Prime Advisors sold out of Zoetis (ZTS) in Q2 2018, closing a stake of 300 shares — an estimated $25K sold.

Cowen Prime Advisors first reported a position in ZTS in Q2 2013 and held it in 11 quarters. The position peaked at $3.3M in Q2 2017. 951 funds tracked by Wall St. Rank hold ZTS as of Q2 2018.

  • Cowen Prime Advisors reported no remaining Zoetis position as of Q2 2018 after selling out during the quarter.
  • Cowen Prime Advisors sold 300 Zoetis shares in Q2 2018, an estimated $25K.
  • Cowen Prime Advisors first reported a position in Zoetis in Q2 2013 and held it in 11 quarters.
  • Cowen Prime Advisors's Zoetis position peaked at $3.3M in Q2 2017.
  • 951 funds tracked by Wall St. Rank held Zoetis as of Q2 2018.

Based on Cowen Prime Advisors's 13F filing for Q2 2018, filed 9 Aug 2018.